Tectonic Therapeutic, Inc.
TECX
$19.02
-$1.45-7.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.57% | -2.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.98% | 22.05% | |||
| Operating Income | 1.98% | -22.05% | |||
| Income Before Tax | -0.14% | -19.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.75% | -25.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.75% | -25.64% | |||
| EBIT | 1.98% | -22.05% | |||
| EBITDA | 2.02% | -22.60% | |||
| EPS Basic | 4.92% | -15.40% | |||
| Normalized Basic EPS | 0.03% | -9.77% | |||
| EPS Diluted | 4.92% | -15.40% | |||
| Normalized Diluted EPS | 0.03% | -9.77% | |||
| Average Basic Shares Outstanding | 0.18% | 8.87% | |||
| Average Diluted Shares Outstanding | 0.18% | 8.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||